Search Results - "Neuromuscular disorders : NMD"
-
1
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016
Published in Neuromuscular disorders : NMD (01-01-2018)“…•Three distinct subtypes of immune-mediated necrotizing myopathies are defined.•New pathological criteria for immune-mediated necrotizing myopathies are…”
Get full text
Journal Article Conference Proceeding -
2
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Published in Neuromuscular disorders : NMD (01-11-2019)“…•NURTURE is an ongoing study of nusinersen started in a presymptomatic stage of SMA.•All infants were ≥25 months old, and alive without permanent…”
Get full text
Journal Article -
3
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Published in Neuromuscular disorders : NMD (01-02-2018)“…•We report an update on standards of care recommendations for spinal muscular atrophy.•The paper provides a review of the recent literature.•Expert opinion is…”
Get full text
Journal Article -
4
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
Published in Neuromuscular disorders : NMD (01-03-2018)“…•We report an update on standards of care recommendations for spinal muscular atrophy.•The paper provides a review of the recent literature.•Expert opinion is…”
Get full text
Journal Article -
5
Rhabdomyolysis: Review of the literature
Published in Neuromuscular disorders : NMD (01-08-2014)“…Highlights • Summary of the pathophysiology, clinical presentation, aetiology, diagnosis, and management of rhabdomyolysis. • Comprehensive overview of…”
Get full text
Journal Article -
6
Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
Published in Neuromuscular disorders : NMD (01-03-2018)“…•The largest series of SMA patients for which SMN2 copy number has been determined.•All relevant studies published on the correlation SMN2 copy-SMA phenotype…”
Get full text
Journal Article -
7
229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017
Published in Neuromuscular disorders : NMD (01-08-2018)“…•A consensus was reached on an updated definition of LGMD, and current sub-types were evaluated by application of the updated definition.•Consensus was reached…”
Get full text
Journal Article Conference Proceeding -
8
Histological effects of givinostat in boys with Duchenne muscular dystrophy
Published in Neuromuscular disorders : NMD (01-10-2016)“…Highlights • HDAC hyperactivity is part of DMD pathogenesis. Givinostat is an HDAC inhibitor. • Givinostat increased muscle and decreased fibrosis and fat…”
Get full text
Journal Article -
9
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
Published in Neuromuscular disorders : NMD (01-01-2020)“…•Dermatomyositis-specific autoantibodies define unique clinical phenotypes.•Standardized autoantibody detection methods are needed.•Patients with…”
Get full text
Journal Article Conference Proceeding -
10
Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
Published in Neuromuscular disorders : NMD (01-06-2021)“…•Newborn screening for SMA is performed today in 9 countries.•Fewer than 2% of the newborns of the whole world are currently screened for SMA.•Respondents are…”
Get full text
Journal Article Web Resource -
11
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials
Published in Neuromuscular disorders : NMD (01-02-2016)“…Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and…”
Get full text
Journal Article -
12
Developmental milestones in type I spinal muscular atrophy
Published in Neuromuscular disorders : NMD (01-11-2016)“…Highlights • The paper reports patterns of natural progression in type 1 SMA. • This is the first time the HINE is used to capture possible changes motor…”
Get full text
Journal Article -
13
Fatigue in patients with myasthenia gravis. A systematic review of the literature
Published in Neuromuscular disorders : NMD (01-08-2020)“…•Central fatigue is highly prevalent in autoimmune Myasthenia Gravis.•There is a strong association with disease severity, female gender and depressive…”
Get full text
Journal Article -
14
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study
Published in Neuromuscular disorders : NMD (01-03-2019)“…•Avalglucosidase alfa (neoGAA) had a well-tolerated safety profile in LOPD patients.•Respiratory and functional capacities were stable or improved in most…”
Get full text
Journal Article -
15
MYO-MRI diagnostic protocols in genetic myopathies
Published in Neuromuscular disorders : NMD (01-11-2019)“…•Whole body MRI (WBMRI) is an important imaging biomarker for myopathies.•Different mutations within the same gene can have different clinical WBMRI…”
Get full text
Journal Article -
16
A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
Published in Neuromuscular disorders : NMD (01-06-2014)“…Abstract The muscular dystrophies are a broad group of hereditary muscle diseases with variable severity. Population-based prevalence estimates have been…”
Get full text
Journal Article -
17
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen
Published in Neuromuscular disorders : NMD (01-07-2021)“…•Real world data on functional changes following nusinersen treatment are needed.•At 12 months from the 1st dose of nusinersen, functional increase was…”
Get full text
Journal Article -
18
Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function
Published in Neuromuscular disorders : NMD (01-07-2018)“…•Report longitudinal experience of using Nusinersen in 104 type 1 SMA patients.•Patients were assessed using the CHOP INTEND and the HINE-II.•Improvements were…”
Get full text
Journal Article -
19
The 2023 version of the gene table of neuromuscular disorders (nuclear genome)
Published in Neuromuscular disorders : NMD (01-01-2023)Get full text
Journal Article -
20
228th ENMC International Workshop:: Airway clearance techniques in neuromuscular disorders Naarden, The Netherlands, 3–5 March, 2017
Published in Neuromuscular disorders : NMD (01-03-2018)“…•This report provides with an algorithmic approach to ACT management in NMDs.•ACTs are employed to compensate for weak respiratory muscles in people with…”
Get full text
Journal Article Conference Proceeding